Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation.
Ontology highlight
ABSTRACT: Increasing evidence shows that microRNAs play an important role in kidney disease. However, functions of long noncoding RNAs (lncRNAs) in kidney diseases remain undefined. We have previously shown that TGF-?1 plays a diverse role in renal inflammation and fibrosis and Smad3 is a key mediator in this process. In this study, we used RNA-sequencing to identify lncRNAs related to renal inflammation and fibrosis in obstructive nephropathy induced in Smad3 wild-type and knockout mice. We found that Arid2-IR was a Smad3-associated lncRNA as a Smad3 binding site was found in the promoter region of Arid2-IR and deletion of Smad3 abolished upregulation of Arid2-IR in the diseased kidney. In vitro knockdown of Arid2-IR from tubular epithelial cells produced no effect on TGF-?-induced Smad3 signaling and fibrosis but inhibited interleukin-1?-stimulated NF-?B-dependent inflammatory response. In contrast, overexpression of Arid2-IR promoted interleukin-1?-induced NF-?B signaling and inflammatory cytokine expression without alteration of TGF-?1-induced fibrotic response. Furthermore, treatment of obstructed kidney with Arid2-IR shRNA blunted NF-?B-driven renal inflammation without effect on TGF-?/Smad3-mediated renal fibrosis. Thus, Arid2-IR is a novel lncRNA that functions to promote NF-?B-dependent renal inflammation. Blockade of Arid2-IR may represent a novel and specific therapy for renal inflammatory disease.
SUBMITTER: Zhou Q
PROVIDER: S-EPMC4817750 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA